Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Healthcare Biotechnology
Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Sernova Corp > How do we determine fair market cap from a licensing deal?
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(2)
•••
Comment by MustangSalleyon May 07, 2021 1:51am
112 Views
Post# 33150152

RE:RE:RE:RE:RE:RE:How do we determine fair market cap from a licensing deal?

RE:RE:RE:RE:RE:RE:How do we determine fair market cap from a licensing deal?
MoneyMouth wrote:
So, no, you are wrong. Why would the immune protection tech prevent any and all deals from being made? See if you can try and give an objective response instead of clouding it with your own bitterness.


Moneymouth you do not understand anything related to this investment if you do not realize that without immunosuppresion solved , you will have no interest from anyone.

The fact you fail to understand this concept tells me you are a novice emotional investor . Some of us have been here for over ten years , you have been her3 for a few months and do not realize how disorganized and inefficient Toleikis is .



<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities